Lymphocytes 6x
Generic Name: lymphocytes 6x
Brand Names:
Lymphocytes 6x
Use: Promotes healthy balance of homologous organs.
Overview
Use: Promotes healthy balance of homologous organs.
Uses
FOR ORAL USE ONLY
Dosage
Directions: Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow. Follow inside instructions to open ampule.
Warnings
Warnings: NOT FOR INJECTION Do not use if allergic to any ingredient. Consult a physician if symptoms worsen. If pregnant or nursing, consult a physician before use. Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Frequently Asked Questions
What is Lymphocytes 6x used for?▼
FOR ORAL USE ONLY
What are the important warnings for Lymphocytes 6x?▼
Warnings: NOT FOR INJECTION Do not use if allergic to any ingredient. Consult a physician if symptoms worsen. If pregnant or nursing, consult a physician before use. Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Related Medications
Acetaminophen 500 Mg, Caffeine 60 Mg, Pyrilamine Maleate 15 Mg
acetaminophen 500 mg, caffeine 60 mg, pyrilamine maleate 15 mg
Dosage form: TABLET, FILM COATED. Active ingredients: ACETAMINOPHEN (500 mg/1); CAFFEINE (60 mg/1); PYRILAMINE MALEATE (15 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Kit For The Preparation Of Technetium Tc 99m Pentetate
kit for the preparation of technetium tc 99m pentetate
Lead Chelator [EPC]
11 DESCRIPTION 11.1 Chemical Characteristics Kit for the Preparation of Technetium Tc 99m pentetate injection, a radioactive diagnostic agent, for intravenous or inhalation use. Each multiple-dose 10 mL glass vial contains a sterile, non-pyrogenic, non-radioactive lyophilized powder of 20 mg of pentetic acid, 5 mg of p-aminobenzoic acid, 3.73 mg of calcium chloride dihydrate, and not less than 0.25 mg stannous chloride dihydrate and not more than 0.385 mg maximum tin expressed as stannous chlori
Emicizumab
emicizumab
11 DESCRIPTION Emicizumab-kxwh is a humanized monoclonal modified immunoglobulin G4 (IgG4) bispecific antibody binding factor IXa and factor X. Emicizumab-kxwh has an approximate molecular weight of 145.6 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells. Emicizumab-kxwh has no structural relationship or sequence homology to FVIII and, as such, does not induce or enhance the development of direct inhibitors to FVIII.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.